Your Location:
Home >
Browse articles >
Xiao Chaihutang Combined with Erchen Tang Ameliorates Metabolic-associated Fatty Liver Disease in Mice by Regulating SIRT1/PGC-1α /PPARα Signaling Pathway
Xiao Chaihutang Combined with Erchen Tang Ameliorates Metabolic-associated Fatty Liver Disease in Mice by Regulating SIRT1/PGC-1
Enhanced Publicationα /PPARα Signaling Pathway- Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 18, Pages: 69-76(2026)
DOI: 10.13422/j.cnki.syfjx.20252504
Revised:2025-12-23 ,
Accepted:24 December 2025
Scan QR Code
Full Text(HTML)
Figs( 3 ) Tabs( 6 )
References
Publication Info
Metrics
109
Views
36
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Shaoyao Gancaotang Alleviates High-fat Diet-aggravated Colitis in Mice by Suppressing Ferroptosis Through SLC7A11/GPX4 Signaling Pathway
Danshen Zexie Decoction Alleviates Mitochondrial Dysfunction in Rat Model of MAFLD by Intervening in Mitophagy via PINK1/Parkin Signaling Pathway
Regulatory Effect of Danshen Zexie Decoction on Gut Microbiota-SCFAs-GLP-1 Metabolic Axis in Rat Model of Metabolic-associated Fatty Liver Disease
Danshen Zexie Decoction Ameliorates Metabolic-associated Fatty Liver Disease with Liver Fibrosis by Regulating Glycolysis and Inhibiting NETs
Clinical and Mechanistic Research Progress on Classical Traditional Chinese Medicine Formulas in Treatment of Chronic Heart Failure
Related Author
SHI Juan
GAO Lianyin
ZHANG Xiaohui
JI Jing
MA Chongyang
WANG Xueqian
CHENG Fafeng
XU Tian
Related Institution
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
School of Traditional Chinese Medicine, Beijing University of Chinese Medicine
School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine
School of Traditional Chinese Medicine, Capital Medical University
The First Affiliated Hospital of Hebei University of Chinese Medicine


